Funding for this research was provided by:
Stem Cell Network (13/5536, FY17/PP2)
Canadian Institutes of Health Research (Canadian Institutes of Health Research)
Multiple Sclerosis Society of Vernon
Public Scholar Award, University of British Columbia
Li Tze Fong Memorial Fellowship University of British Columbia Faculty of Medicine
Millie and Ralph Drabinsky Graduate Scholarship in Medicine, University of British Columbia Faculty of Medicine
Faculty of Medicine Graduate Scholarship, University of British Columbia
Text and Data Mining valid from 2018-05-16
Received: 25 July 2017
Accepted: 16 April 2018
First Online: 16 May 2018
Ethics approval and consent to participate
: This study was reviewed and approved by the University of British Columbia Research Ethics Board (H13–03275). All participants granted informed consent to participate in the study.
: A. Traboulsee is Principal Investigator on CIHR and MS Society of Canada supported Phase II clinical trial of venoplasty for the treatment of CCSVI in MS.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.